Clinical Trial Update: Study of Hypoxia Measured in F-Miso PET/Scan and MRI in Patients With Squamous Cells Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating hypoxia assessment in oropharyngeal squamous cell carcinoma using 18F-FMISO PET and MRI; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: Centre Henri Becquerel | Conditions: Squamous Cell Carcinoma of the Oropharynx | Phase 2 | Status: COMPLETED